These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21685220)

  • 1. Is surgery indicated in patients with stage IIIa lung cancer and mediastinal nodal involvement?
    Bakir M; Fraser S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):303-10. PubMed ID: 21685220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior?
    Hughes MJ; Chowdhry MF; Woolley SM; Walker WS
    Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):311-5. PubMed ID: 21606053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does surgery have a role in T4N0 and T4N1 lung cancer?
    Chambers A; Routledge T; Billè A; Scarci M
    Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):473-9. PubMed ID: 20621998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
    Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
    Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
    Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present status of surgery for lung cancer.
    Lacquet LK
    Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operative results of non-small cell lung cancer clinically presenting mediastinal lymph adenopathy.
    Yoshino I; Yamaguchi M; Yohena T; Kameyama T; Kometani T; Osoegawa A; Maehara Y
    Fukuoka Igaku Zasshi; 2003 Aug; 94(8):250-8. PubMed ID: 14579727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
    Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
    Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
    Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
    Cerfolio RJ; Bryant AS; Minnich DJ
    Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.